OnKure Therapeutics (OKUR) Other Working Capital Changes (2020 - 2026)

OnKure Therapeutics (OKUR) has reported Other Working Capital Changes for 7 consecutive years, with -$89000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes rose 72.7% year-over-year to -$89000.0; the trailing twelve-month figure through Jun 2026 stood at $151000.0 (up 103.3% YoY), and the FY2025 full-year result was -$536000.0, up 76.24% from the prior year.
• Other Working Capital Changes advanced to -$89000.0 in Q2 2026 per OKUR's latest filing, from -$281000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $3.5 million in Q4 2023 and bottomed at -$2.1 million in Q4 2024.
• Historically, Other Working Capital Changes has averaged -$141277.8 across 5 years, with a median of -$261000.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes sank 316.47% in 2022, then jumped 1214.18% in 2023.
• Over 5 years, Other Working Capital Changes stood at $268000.0 in 2022, then surged by 1214.18% to $3.5 million in 2023, then plunged by 159.68% to -$2.1 million in 2024, then surged by 124.55% to $516000.0 in 2025, then plunged by 117.25% to -$89000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$89000.0, -$281000.0, and $516000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.